Date Title Description PDF
02 Mar 2021 On business and financial situation The Company releases a presentation related to an update of the regulatory processes of its long-acting injectable antipsychotic, Doria®, both in Europe and the United States  Download
24 Feb 2021 About corporate governance The Company informs about the agreements adopted by the Board of Directors  Download
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
24 Feb 2021 On business and financial situation ROVI releases the 2020 Results presentation Download
24 Feb 2021 Annual Corporate Governance Report ROVI releases the 2020 Annual Corporate Governance Report Download
24 Feb 2021 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2020 annual report regarding remuneration of the members of the Board of Directors  Download
11 Jan 2021 Liquidity contracts and specialists Liquidity contract: transactions conducted in the fourth quarter of 2020 Download
24 Nov 2020 On business and financial situation The Company releases the presentation related to its strategy update because of the 2020 Capital Markets Day. Download

Pages

Date Title Description PDF
04 Oct 2018 Share capital increases and reductions Private placement capital increase addressed to institutional investors, excluding  preferential subscription rights Download
02 Oct 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the third quarter of 2018 Download
24 Sep 2018 Others on business performance and financial information Updated information on business, financial position and risk factors Download
24 Sep 2018 Share capital increases and reductions Intention to raise gross proceeds by means of an offer addressed to institutional investors, excluding preferential subscription rights Download
26 Jul 2018 Información sobre resultados ROVI releases the 2018 first half results presentation Download

Pages